155 related articles for article (PubMed ID: 3406453)
1. Time-dose response of human tumors and normal tissues during and after fractionated radiation treatment. A new model.
van de Geijn J
Radiother Oncol; 1988 May; 12(1):57-78. PubMed ID: 3406453
[TBL] [Abstract][Full Text] [Related]
2. Tumour and normal tissue responses to fractionated non-uniform dose delivery.
Källman P; Agren A; Brahme A
Int J Radiat Biol; 1992 Aug; 62(2):249-62. PubMed ID: 1355519
[TBL] [Abstract][Full Text] [Related]
3. Modeling the effect of intratumoral heterogeneity of radiosensitivity on tumor response over the course of fractionated radiation therapy.
Alfonso JCL; Berk L
Radiat Oncol; 2019 May; 14(1):88. PubMed ID: 31146751
[TBL] [Abstract][Full Text] [Related]
4. Derivation of the optimum dose per fraction from the linear quadratic model.
Jones B; Tan LT; Dale RG
Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
[TBL] [Abstract][Full Text] [Related]
5. Cell kinetics and radiation biology.
Denekamp J
Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Feb; 49(2):357-80. PubMed ID: 3510997
[TBL] [Abstract][Full Text] [Related]
6. Fractionated radiation therapy after Strandqvist.
Fowler JF
Acta Radiol Oncol; 1984; 23(4):209-16. PubMed ID: 6093436
[TBL] [Abstract][Full Text] [Related]
7. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.
Kirkpatrick JP; Meyer JJ; Marks LB
Semin Radiat Oncol; 2008 Oct; 18(4):240-3. PubMed ID: 18725110
[TBL] [Abstract][Full Text] [Related]
8. Numerical simulation of normal and cancer cells' populations with fractional derivative under radiotherapy.
Farayola MF; Shafie S; Mohd Siam F; Khan I
Comput Methods Programs Biomed; 2020 Apr; 187():105202. PubMed ID: 31835107
[TBL] [Abstract][Full Text] [Related]
9. Radiogenic responses of normal cells induced by fractionated irradiation--a simulation study. Part II. Late responses.
Düchting W; Ulmer W; Ginsberg T; Kikhounga-N'Got O; Saile C
Strahlenther Onkol; 1995 Sep; 171(9):525-33. PubMed ID: 7570301
[TBL] [Abstract][Full Text] [Related]
10. Individual Response to Ionizing Radiation and Personalized Radiotherapy.
Domina EA; Philchenkov A; Dubrovska A
Crit Rev Oncog; 2018; 23(1-2):69-92. PubMed ID: 29953368
[TBL] [Abstract][Full Text] [Related]
11. An effective dose computation model for fractionated radiation dose.
Akanuma A
Radiat Med; 1983; 1(2):155-60. PubMed ID: 6679907
[TBL] [Abstract][Full Text] [Related]
12. Optimal number and sizes of the doses in fractionated radiotherapy according to the LQ model.
Bruni C; Conte F; Papa F; Sinisgalli C
Math Med Biol; 2019 Mar; 36(1):1-53. PubMed ID: 29346681
[TBL] [Abstract][Full Text] [Related]
13. Arrhenius relationships from the molecule and cell to the clinic.
Dewey WC
Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
[TBL] [Abstract][Full Text] [Related]
14. Computer simulation and modelling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy.
Düchting W; Ulmer W; Lehrig R; Ginsberg T; Dedeleit E
Strahlenther Onkol; 1992 Jun; 168(6):354-60. PubMed ID: 1320297
[TBL] [Abstract][Full Text] [Related]
15. Dose-response curve and split-dose recovery in human skin cancer.
Trott KR; Maciejewski B; Preuss-Bayer G; Skolyszewski J
Radiother Oncol; 1984 Aug; 2(2):123-9. PubMed ID: 6505282
[TBL] [Abstract][Full Text] [Related]
16. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of altered fractionation theory].
Sakata K; Someya M; Nakata K; Takagi M; Hareyama M
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1823-6. PubMed ID: 19011329
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
Stuschke M; Budach V; Stüben G; Streffer C; Sack H
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
[TBL] [Abstract][Full Text] [Related]
19. From cell population models to tumor control probability: including cell cycle effects.
Hillen T; de Vries G; Gong J; Finlay C
Acta Oncol; 2010 Nov; 49(8):1315-23. PubMed ID: 20843174
[TBL] [Abstract][Full Text] [Related]
20. Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology.
Yang Y; Xing L
Med Phys; 2005 Dec; 32(12):3666-77. PubMed ID: 16475766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
